Clinical Trial Update: A Combined Cell Therapy Approach to the Treatment of Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a combined cell therapy for neuroblastoma has been withdrawn. The sponsor is H. Lee Moffitt Cancer Center and Research Insti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Neuroblastoma, Neoplasms, Nerve Tissue | Phase 1 | Status: WITHDRAWN